christine grady, "why do we offer payment to research participants, and what are the regulatory...
Upload: the-petrie-flom-center-for-health-law-policy-biotechnology-and-bioethics
Post on 23-Jan-2018
109 views
TRANSCRIPT
BIOETHICS AT THE NIH
Why Do We Offer Payment to Research Participants, and What Are the Regulatory
Parameters?
Models of conceptualizing payment
Christine Grady Department of Bioethics
NIH Clinical Center December 9, 2016.
BIOETHICS AT THE NIH
Disclaimer
The views expressed are my own and do not represent the positions or policies of the NIH, DHHS, or US government I have no conflicts of interest to disclose
BIOETHICS AT THE NIH
Why do we offer payment to research participants?
• “It is a poorly kept secret in the world of clinical trials that issues with patient recruitment and enrollment are the primary causes for missing clinical trial timelines. Most of us have seen the data. We know that for each day a company goes beyond the planned deadline for a clinical trial, that company could be losing as much as $600,000 in foregone sales of smaller products and as much as $8 million on blockbuster drugs. As necessity is the mother of invention, it comes as no surprise that sponsors and CROs are looking to any and all means by which to increase the rate of patient enrollment.”
ISR-The Expanding Web of Patient Recruitment, 2014
BIOETHICS AT THE NIH
Why do we offer payment to research participants?
• We offer payment to enhance participant recruitment and enrollment
• Does offering payment to research participants increase the rate of enrollment? Survey response rates Healthy volunteer studies Clinical trials?
BIOETHICS AT THE NIH
Treweek S. et al Methods to Improve Recruitment to Clinical Trials Cochrane Review 2013
BIOETHICS AT THE NIH
Treweek S. et al Methods to Improve Recruitment to Clinical Trials Cochrane Review. BMJ Open 2013
*3 studies- two hypothetical
BIOETHICS AT THE NIH
Why do we offer payment to research participants?
• Enable participation
• Make participation - revenue-neutral
• Compensate for time, contribution, risk
• Minimize possibility of exploitation
• Demonstrate respect and gratitude
(Payment for any of these reasons might facilitate recruitment)
BIOETHICS AT THE NIH
Models for paying research participants
• Market model
• Wage payment model
• Reimbursement model
• Appreciation model
BIOETHICS AT THE NIH
Models for paying research participants
• Market model- incentives, risk
• Wage payment model- time and contribution, enabling participation
• Reimbursement model- expenses, revenue-
neutral
• Appreciation model- respect/gratitude
BIOETHICS AT THE NIH
Dickert N, Grady C. 1999
BIOETHICS AT THE NIH
Reimbursement model
Advantages • Reduces financial sacrifice
of participants • Does not preferentially
favor any one group • Provides no incentive to
conceal information or remain uninformed
• Reduces chance of money unduly influencing decisions
Disadvantages • May not act as sufficient
incentive for recruitment • Leaves time
uncompensated • if time reimbursed: • Pays differentially for same
function • May lead to targeting lower
paid individuals
BIOETHICS AT THE NIH
Market model
AAdvantages • Likely to enhance/facilitate
recruitment • Reduces financial sacrifice
of participants- in fact, they may profit
Disadvantages • May provide incentive to
remain uninformed or to misrepresent
• May be unduly influential • May lead to interstudy
competition (crowding out)
BIOETHICS AT THE NIH
Appreciation model
Advantages • Rewards valuable
contribution • Expresses appreciation
without undermining volunteerism
• Might enhance recruitment*
Disadvantages • Might not affect
recruitment • Still requires financial
sacrifice • No basis for determining
magnitude of “reward”
BIOETHICS AT THE NIH
Wage payment
Advantagesd • Provides standardization
across studies • Adheres to the principle of
justice by paying similar amounts for similar contribution
• Reduces potential for undue inducement
• Reduces financial sacrifice and provides some wage
Disadvantages • Might not be adequate for
recruitment • Financial sacrifice for
wealthier population, more attractive to financially disadvantaged
BIOETHICS AT THE NIH
Largent et al. 2012
BIOETHICS AT THE NIH
Objections to the wage payment model
1. Too restrictive/paternalistic. Payment should be more liberal
2. Should be controlled/regulated, work environment
3. Still may be unduly influential
BIOETHICS AT THE NIH
Phillips, T JLME 2011
BIOETHICS AT THE NIH
Deciding whether and how much payment to offer to research participants
• Models respond to justification for offering payment and provide general guidance regarding how
• Consideration of institutional guidelines, local societal, legal, cultural norms
• Details
BIOETHICS AT THE NIH
• Thank you